248 related articles for article (PubMed ID: 11014174)
1. AIDS. Escape from the immune system.
Walker BD; Goulder PJ
Nature; 2000 Sep; 407(6802):313-4. PubMed ID: 11014174
[No Abstract] [Full Text] [Related]
2. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
3. New finding on immune response to HIV Tat may contribute to vaccine, treatment.
James JS
AIDS Treat News; 2000 Sep; (351):4. PubMed ID: 12173551
[TBL] [Abstract][Full Text] [Related]
4. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
Allen TM; O'Connor DH; Jing P; Dzuris JL; Mothé BR; Vogel TU; Dunphy E; Liebl ME; Emerson C; Wilson N; Kunstman KJ; Wang X; Allison DB; Hughes AL; Desrosiers RC; Altman JD; Wolinsky SM; Sette A; Watkins DI
Nature; 2000 Sep; 407(6802):386-90. PubMed ID: 11014195
[TBL] [Abstract][Full Text] [Related]
5. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
6. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
Yang OO
Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
[No Abstract] [Full Text] [Related]
7. HIV and SIV CTL escape: implications for vaccine design.
Goulder PJ; Watkins DI
Nat Rev Immunol; 2004 Aug; 4(8):630-40. PubMed ID: 15286729
[No Abstract] [Full Text] [Related]
8. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.
Maggiorella MT; Baroncelli S; Michelini Z; Fanales-Belasio E; Moretti S; Sernicola L; Cara A; Negri DR; Buttò S; Fiorelli V; Tripiciano A; Scoglio A; Caputo A; Borsetti A; Ridolfi B; Bona R; ten Haaft P; Macchia I; Leone P; Pavone-Cossut MR; Nappi F; Ciccozzi M; Heeney J; Titti F; Cafaro A; Ensoli B
Vaccine; 2004 Sep; 22(25-26):3258-69. PubMed ID: 15308348
[TBL] [Abstract][Full Text] [Related]
9. Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability.
Ridolfi B; Genovese D; Argentini C; Maggiorella MT; Sernicola L; Buttò S; Titti F; Borsetti A; Ensoli B
Virus Genes; 2008 Feb; 36(1):105-15. PubMed ID: 18049888
[TBL] [Abstract][Full Text] [Related]
10. A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading frames.
Klase Z; Donio MJ; Blauvelt A; Marx PA; Jeang KT; Smith SM
Retrovirology; 2006 Jan; 3():1. PubMed ID: 16398928
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T-lymphocyte escape monitoring in simian immunodeficiency virus vaccine challenge studies.
O'Connor DH; Allen TM; Watkins DI
DNA Cell Biol; 2002 Sep; 21(9):659-64. PubMed ID: 12396608
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.
Matano T; Kobayashi M; Igarashi H; Takeda A; Nakamura H; Kano M; Sugimoto C; Mori K; Iida A; Hirata T; Hasegawa M; Yuasa T; Miyazawa M; Takahashi Y; Yasunami M; Kimura A; O'Connor DH; Watkins DI; Nagai Y
J Exp Med; 2004 Jun; 199(12):1709-18. PubMed ID: 15210746
[TBL] [Abstract][Full Text] [Related]
13. New gene-based approaches for an AIDS vaccine.
Puaux AL; Michel ML
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):357-72. PubMed ID: 12818622
[TBL] [Abstract][Full Text] [Related]
14. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
Kent SJ; Fernandez CS; Dale CJ; Davenport MP
Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
[TBL] [Abstract][Full Text] [Related]
15. Differential patterns of immune escape at Tat-specific cytotoxic T cell epitopes in pigtail macaques.
Mason RD; De Rose R; Kent SJ
Virology; 2009 Jun; 388(2):315-23. PubMed ID: 19394064
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.
Cristillo AD; Lisziewicz J; He L; Lori F; Galmin L; Trocio JN; Unangst T; Whitman L; Hudacik L; Bakare N; Whitney S; Restrepo S; Suschak J; Ferrari MG; Chung HK; Kalyanaraman VS; Markham P; Pal R
Virology; 2007 Sep; 366(1):197-211. PubMed ID: 17499328
[TBL] [Abstract][Full Text] [Related]
17. Aids vaccine advance.
Novak K; MacFarlane J; Aamodt S
Nat Med; 2000 Nov; 6(11):1220. PubMed ID: 11062531
[No Abstract] [Full Text] [Related]
18. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
[TBL] [Abstract][Full Text] [Related]
19. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.
Fernandez CS; Smith MZ; Batten CJ; De Rose R; Reece JC; Rollman E; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Apr; 81(8):4137-44. PubMed ID: 17251297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
